Article
A novel KEL*1,3 allele with weak Kell antigen expression confirming the cis-modifier effect of KEL3.
Transfusion - 1 Apr 2009
Körmöczi Günther F, Scharberg Erwin A, Gassner Christoph
Abstract excerpt
BACKGROUND: KEL1 (K) is the most immunogenic red blood cell antigen of the Kell blood group system. The frequently occurring anti-KEL1 alloantibodies may cause hemolytic transfusion reactions as well as severe hemolytic disease of the fetus and newborn. So far, reports on weak KEL phenotypes are scarce. STUDY DESIGN AND METHODS: Blood samples of two unrelated Central European propositi with faint reactions in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
